However, evidence on longer-term outcomes, side effects, and potential conflicts of interest remains limited or uncertain
Sources / References The New England Journal of Medicine (NEJM) Phase 2 Trial (Primary Peer-Reviewed Study) Jastreboff AM, Kaplan LM, Fras JP, et al
The timing connection: understanding when your appetite will be lowest (peak drug levels, days 1 to 3) lets you plan your highest-protein meals for the days when you have relatively more appetite (days 5 to 7)
Meals for nausea-heavy periods During dose escalation phases, nausea can be intense enough to make even GLP-1 friendly meals challenging
Obesity Management Retatrutide is most notably being developed for weight loss
Compared with the structure of human GLP-1(7-37), the amino acid sequence of dulaglutide contains glycine at position 8, glutamic acid at position 22, and glycine at position 36